Root Financial Partners
NKTR icon

Root Financial Partners’s Nektar Therapeutics NKTR Stock Holding History

Root Financial Partners’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.06K Buy
+34
New +$2.39K ﹤0.01% 2628
2026
Q2 		– Sell
-1
Closed -$72 – 2192
2026
Q1 		$72 Buy
+1
New +$57 ﹤0.01% 3336

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Prosight Management
Prosight Management Dallas, Texas $515M AUM 2.95% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Root Financial Partners's NKTR Position: Q3 2026 in Review

Root Financial Partners opened a new position in Nektar Therapeutics (NKTR) in Q3 2026: 34 shares worth $2.06K. The stake represents ﹤0.01% of the portfolio and ranks #2628 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in NKTR as recently as Q1 2026.

Root Financial Partners first reported a position in NKTR in Q1 2026 and has held it in 2 quarters since. 168 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.

  • Root Financial Partners held 34 shares of Nektar Therapeutics worth $2.06K as of Q3 2026.
  • Nektar Therapeutics was a new Root Financial Partners position in Q3 2026.
  • Nektar Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #2628 holding.
  • Root Financial Partners first reported a position in Nektar Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 168 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.